The Latest Blatant Penny Pump & Dump You Should Know About

Oh, you thought SPNG and GVBP were the only 2 penny to partake in shady, sketchy dealings? (Remember, this penny stock manipulation blog post is a MUST READ.) No way, those are just two convicts in a prison full of dangerous felons. You get the analogy.

I would’ve gone into such detail as this Dow Jones NewsPlus article, but I haven’t been able to find any shares to of this stock, so congrats to the few TIMalert subscribers and others who have (they are floating around there, this is easy money!!!)

For the rest of us, we can just read this stuff and learnnnnn. I don’t care if it’s a Friday afternoon, pump & dumps come all year round, you either want to be one of the few who enjoy easy well-researched profits or you want to be one of the many lazy Americans who want to get rich without working for it. Choose.

BioNeutral Group Inc. (BONU) is one of the many companies hoping to benefit from the swine flu pandemic, thanks to a disinfectant that it says can contain the nasty bug.

Caution would seem to be warranted considering the company hasn’t yet brought a product to market, has had no revenue recently and has even warned about its viability. Investors might also want to consider the company’s inability to answer even the most basic questions about the status of its trademark applications and the background of a large investor and director.

A spokeswoman for BioNeutral didn’t answer any questions about the company and its management. Several messages left on BioNeutral’s answering machine weren’t returned, and emails to press relations staff received no response.

Among those involved: Lebed.biz said it received $20,000; Thestockscout.com said it got $230,000 and 100,000 free trading shares; Flaherty Financial News Inc. said it got $20,000 from Red Rock Marketing Media and $10,000 from Creative marketing Group; and Stockegg.com said it received $65,000 from DC Media LLC.

Third-party payments to promote stock aren’t new in the Over-the-Counter-Bulletin-Board market, where BioNeutral trades, but investors should be aware that there are firms getting paid to tout the stock.

The group, founded by former Department of Homeland head Michael Chertoff, will receive a 10% equity interest in BioNeutral over the next three years for its work. The group is also getting paid a minimum monthly cash compensation of $75,000. Runge said the group’s decision to take on BioNeutral as a client was independent of its stock price.

According to the U.S. Patent and Trademark Office online database, BioNeutral Laboratories originally applied to trademark Ygiene and Ogiene in 2005 and 2006. According to the PTO database, the applications were deemed “abandoned” in November 2008. A lawyer for BioNeutral filed a new application to trademark Ogiene on July 31, 2009. That same lawyer filed a trademark application for Ygiene on that same date, almost three months after another wannabe flu fighter named Pure Bioscience Corporation (PURE) filed its own trademark application for the name.

Philip Tierno, director of clinical microbiology at New York University and a consultant to BioNeutral, said he had been approached by Novelle a few years back. Tierno described the new product Ygiene as the “serendipitous combination of three ingredients” that gave BioNeutral the ability to make very the formula to hit any kind of organism.

Information available in an online broker dealer database shows that a RP between 1986 and 1997 worked for several brokerage firms, some of which were plagued by large numbers of customer complaints. According to Pamani’s official BioNeutral biography, he was “instrumental in taking public” a number of biotech companies in the past. Three of the five companies mentioned in the biography were taken public by brokerage firms where Pamnani worked at the time.

In 1986, the RP who appeared in the database worked at Blinder, Robinson & Co., a brokerage firm that got into trouble over its sales practices for penny stocks. Blinder Robinson was later known in the industry as “Blind “em and Rob “em.”

After leaving Blinder, this Pamnani joined Kureen & Cooper, a firm whose president, Paul Russo, was later convicted of . After Kureen & Cooper closed, Pamnani worked for Richmond Securities Inc. from 1986 to 1990. The firm was expelled from the industry by brokerage regulator NASD, now FINRA, in 1995 for failing to pay fines levied after it was accused of overcharging customers.